Delivery Order SPE2DB22D9239-SPE2DB24FDJ50

Award Date 5/8/24
Potential Completion Date 5/30/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order, valued at $40,443.20, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML to support the recurring pharmaceutical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract has a ceiling value of $40,443.20 and a performance period through August 30, 2024. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,338.24, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
The U.S. Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a medication, with a period of performance through September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,626.96, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to $499,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.48, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a prescription drug product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,540.68 firm fixed-price contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of April 18, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDJ50
    Delivery Order

This is a delivery order under the SPE2DB indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $20,221.60 firm fixed-price delivery order is for the provision of EYLEA HD 8 MG/0.07 ML pharmaceutical vials to support the recurring medical supply needs of military health facilities. The award has a May 30, 2024 ultimate completion date and does not utilize a set-aside. This order is part of DMS Pharmaceutical Group's larger $499,999,999 IDC with the DLA, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the medical supply requirements of Department of Defense (DoD) healthcare facilities worldwide.

Generated 8/7/24, 10:31 AM